Future Market Insights, a leading market research firm, has recently released a comprehensive study forecasting a significant surge in the Global Chronic Pulmonary Hypertension Treatment Industry. The market, currently valued at US$ 7 billion in 2023, is expected to witness a robust CAGR of 5%, reaching a remarkable US$ 11.4 billion by the year 2033. …